TD Asset Management’s Palvella Therapeutics PVLA Stock Holding History
Bought
Maintained
Sold
Other funds holding PVLA
TD Asset Management's PVLA Position: Q3 2026 in Review
TD Asset Management reduced its Palvella Therapeutics (PVLA) stake by 2.6% in Q3 2026, selling an estimated $89K and leaving 22,146 shares worth $3.08M. The position accounts for ﹤0.01% of the portfolio, ranked #879.
TD Asset Management first reported a position in PVLA in Q1 2026 and has held it in 3 quarters since. The position peaked at $3.48M in Q2 2026. 199 funds tracked by Wall St. Rank hold PVLA as of Q3 2026.
- TD Asset Management held 22,146 shares of Palvella Therapeutics worth $3.08M as of Q3 2026.
- TD Asset Management sold 600 Palvella Therapeutics shares in Q3 2026, an estimated $89K.
- Palvella Therapeutics made up ﹤0.01% of TD Asset Management's portfolio in Q3 2026, its #879 holding.
- TD Asset Management first reported a position in Palvella Therapeutics in Q1 2026 and has held it in 3 quarters since.
- TD Asset Management's Palvella Therapeutics position peaked at $3.48M in Q2 2026.
- 199 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q3 2026.
Based on TD Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.